AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Acquisition
Company has incorporated a new step-down subsidiary in Russia26-07-2023
26-07-2023
AUROBINDO PHARMA LTD. - 524804 - Revised Disclosure Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Related Party Transactions For The Half Year Ended March 31, 202
Please find revised Related Party Transaction disclosures for the half year ended 31.03.202326-07-2023
Aurobindo Pharma hits 52-week high on FDA clean chit to Telangana unit
The United States Food and Drug Administration (USFDA) inspected the Unit I, a Formulation manufacturing facility, of Eugia Pharma Specialities26-07-2023
AUROBINDO PHARMA LTD. - 524804 - Completion Of US FDA Inspection At Unit I Of Eugia Pharma Specialities Ltd
Completion of US FDA Inspection at Unit I of Eugia Pharma Specialities Limited with classification of No Action Indicated26-07-2023
Aurobindo Pharma arm gets USFDA nod for Plerixafor injection
The approval granted by the US Food Drug Administration (USFDA) is to manufacture and market Plerixafor Injection of strengths 24 mg/1.2 mL (20 mg/mL), single-dose vial, Aurobindo Pharma said in a regulatory filing.25-07-2023
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release in connection with USFDA approval received by Eugia Pharma Specialities Limited, a wholly owned subsidiary of the Company.25-07-2023
Aurobindo Pharma gets 3 observations from USFDA, stock rebounds from early losses
The observations are procedural in nature and we will respond to the USFDA within the stipulated timelines, company said in its release.24-07-2023
AUROBINDO PHARMA LTD. - 524804 - Completion Of US FDA Inspection At Our Unit III - Reg.,
Completion of US FDA Inspection at Company''s Unit III21-07-2023
USFDA indicates voluntary action for Aurobindo Pharma's AP Plant
The U.S. regulator conducted an inspection of unit XIVfrom May 15 to 19, 2023.17-07-2023
AUROBINDO PHARMA LTD. - 524804 - Classification Of US FDA Inspection At Our Unit XIV, Anakapalli District, Andhra Pradesh - Reg
The Company''s Unit XIV has received EIR classifying the facility as voluntary action indicated.17-07-2023